Systemic administration of anti-CD20 indirectly reduces B cells in the inflamed meninges in a chronic model of central nervous system autoimmunity

被引：0
|
作者：
Kerfoot, Steven [1 ]
Tesfagiorgis, Yodit [1 ]
Kemal, Eden A. [1 ]
Craig, Heather C. [1 ]
Parham, Kate A. [1 ]
机构：
[1] Univ Western Ontario, London, ON, Canada
来源：
JOURNAL OF IMMUNOLOGY | 2023年 / 210卷 / 01期
关键词：
D O I：
10.4049/jimmunol.210.Supp.85.05
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [11] Anti-CD20 treatment and neutrophil function in central nervous system demyelinating diseases
    Balazs, Irina
    Horvath, Angela
    Heschl, Bettina
    Khalil, Michael
    Enzinger, Christian
    Stadlbauer, Vanessa
    Seifert-Held, Thomas
    JOURNAL OF NEUROIMMUNOLOGY, 2023, 381
  • [12] B-Cell Activation Influences T-Cell Polarization and Outcome of Anti-CD20 B-Cell Depletion in Central Nervous System Autoimmunity
    Weber, Martin S.
    Prod'homme, Thomas
    Patarroyo, Juan C.
    Molnarfi, Nicolas
    Karnezis, Tara
    Lehmann-Horn, Klaus
    Danilenko, Dimitry M.
    Eastham-Anderson, Jeffrey
    Slavin, Anthony J.
    Linington, Christopher
    Bernard, Claude C. A.
    Martin, Flavius
    Zamvil, Scott S.
    ANNALS OF NEUROLOGY, 2010, 68 (03) : 369 - 383
  • [13] Imaging and therapy with rituximab anti-CD20 immunotherapy in an animal model of central nervous system lym phoma
    Muldoon, Leslie L.
    Lewin, Seth J.
    Dosa, Edit
    Pagel, Michael A.
    Doolittle, Nancy D.
    Neuwelt, Edward A.
    CANCER RESEARCH, 2011, 71
  • [14] Fatal underhanded chronic enterovirus infection associated with anti-CD20 monotherapy for central nervous system demyelinating disease
    Luciani, Lea
    Ninove, Laetitia
    Zandotti, Christine
    Chalvignac, Virginie
    Lagier, David
    Baume, Julien
    Melade, Julien
    Piorkowski, Geraldine
    Coutard, Bruno
    Lepidi, Hubert
    Pelletier, Jean
    Audoin, Bertrand
    Rico-Lamy, Audrey
    Nougairede, Antoine
    MULTIPLE SCLEROSIS JOURNAL, 2021, 27 (02) : 320 - 323
  • [15] Intraventricular treatment of relapsed central nervous system lymphoma with the anti-CD20 antibody rituximab
    Schulz, H
    Pels, H
    Schmidt-Wolf, I
    Zeelen, U
    Germing, U
    Engert, A
    HAEMATOLOGICA, 2004, 89 (06) : 753 - 754
  • [16] Complement activation and resistance within the CSF following intraventricular administration of anti-CD20 in the treatment of central nervous system lymphoma
    Kadoch, Cigall
    Karrim, Juliana
    Shuman, Marc
    Rubenstein, James
    NEURO-ONCOLOGY, 2007, 9 (04) : 510 - 510
  • [17] Activated B Cells Participating in the Anti-Myelin Response Are Excluded from the Inflamed Central Nervous System in a Model of Autoimmunity that Allows for B Cell Recognition of Autoantigen
    Tesfagiorgis, Yodit
    Zhu, Sarah L.
    Jain, Rajiv
    Kerfoot, Steven M.
    JOURNAL OF IMMUNOLOGY, 2017, 199 (02) : 449 - 457
  • [18] Complement activation in circulation and central nervous system after Rituximab (Anti-CD20) treatment of B-Cell lymphoma
    Harjunpää, A
    Wiklund, T
    Collan, J
    Janes, R
    Rosenberg, J
    Lee, D
    Grillo-López, A
    Meri, S
    LEUKEMIA & LYMPHOMA, 2001, 42 (04) : 731 - 738
  • [19] A Transgenic Model of Central Nervous System Autoimmunity Mediated by CD4+ and CD8+ T and B Cells
    Anderson, Ana C.
    Chandwaskar, Rucha
    Lee, David H.
    Sullivan, Jenna M.
    Solomon, Adam
    Rodriguez-Manzanet, Roselynn
    Greve, Bernhard
    Sobel, Raymond A.
    Kuchroo, Vijay K.
    JOURNAL OF IMMUNOLOGY, 2012, 188 (05) : 2084 - 2092
  • [20] Primary central nervous system lymphoma: Current state of anti-CD20 therapy and appraisal of reported response criteria
    Siegal, Tali
    JOURNAL OF CLINICAL NEUROSCIENCE, 2014, 21 (05) : 709 - 715
12345